NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.26 Billion | 18.16 Billion | 21.68 Billion | 17.07 Billion | 19.22 Billion | 16.17 Billion |
| Net Income | 23.21 Billion | 17.02 Billion | 17.71 Billion | 18.13 Billion | 19.24 Billion | 15.36 Billion |
| Depreciation & Amortization | 1.61 Billion | 1.56 Billion | 1.45 Billion | 1.45 Billion | 1.19 Billion | 834.92 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 107.04 Million | - |
| Change in working capital | -2.57 Billion | -1.39 Billion | 1.03 Billion | -4.47 Billion | -1.66 Billion | -2.75 Billion |
| Other non-cash items | 5.45 Billion | 4.97 Billion | 3.3 Billion | 6.2 Billion | 2.89 Billion | 7.84 Billion |
| Investing Cash Flow | -16.35 Billion | -8.79 Billion | -16.68 Billion | -4.73 Billion | -53.2 Billion | -8.86 Billion |
| Investments in PPE | -20.82 Billion | -806.42 Million | -478.11 Million | -790.35 Million | -1.81 Billion | -2.08 Billion |
| Acquisitions | 910 Thousand | 150 Thousand | 854.54 Thousand | 18.18 Thousand | - | 1.8 Million |
| Investment purchases | -186.61 Billion | -212.99 Billion | -114 Billion | -104 Billion | -129.75 Billion | -39.33 Billion |
| Sales/Maturities of investments | 191.1 Billion | 205 Billion | 97.99 Billion | 100 Billion | 78.35 Billion | 32.56 Billion |
| Other Investing Activities | -12.59 Million | 6.59 Million | -210.21 Million | 51.02 Million | 9.17 Million | -5.48 Million |
| Financing Cash Flow | -5.91 Billion | -5.75 Billion | -9.51 Billion | -6.56 Billion | 31.04 Billion | -3.16 Billion |
| Debt repayment | -534.02 Million | -494.56 Million | -4 Billion | -400 Million | -4 Billion | -400 Million |
| Dividends payments | -5.47 Billion | -5.47 Billion | -5.08 Billion | -5.86 Billion | -4.59 Billion | -3.53 Billion |
| Common Stock Repurchased | - | - | - | - | -324.8 Million | - |
| Common Stock Issuance | - | - | - | - | 31.97 Billion | - |
| Other Financing Activities | 91.79 Million | 218.63 Million | -62.12 Million | 16.23 Million | -308.31 Thousand | -24.68 Million |
| Accounts receivables | -2.1 Billion | 865.13 Million | 1.02 Billion | 476.45 Million | -265.09 Million | -1.63 Billion |
| Accounts payables | 2.73 Billion | -643.79 Million | 152.91 Million | 1.02 Billion | -301.51 Million | 702.25 Million |
| Inventory | -1.83 Billion | -1.1 Billion | -94.7 Million | -2.83 Billion | 516.94 Million | -2.51 Billion |
| Other working capital | -1.36 Billion | -504.57 Million | -49.7 Million | -3.14 Billion | -1.61 Billion | 698.78 Million |
| Cash at beginning of period | 10.88 Billion | 7.04 Billion | 11.18 Billion | 5.51 Billion | 8.42 Billion | 4.24 Billion |
| Cash at end of period | 11.88 Billion | 10.88 Billion | 7.04 Billion | 11.18 Billion | 5.51 Billion | 8.42 Billion |
| Capital Expenditure | -20.82 Billion | -806.42 Million | -478.11 Million | -790.35 Million | -1.81 Billion | -2.08 Billion |
| Effect of forex changes on cash | 4.78 Million | 223.42 Million | 387 Million | -91.54 Million | 27.71 Million | 26.82 Million |
| Net cash flow / Change in cash | 998.06 Million | 3.83 Billion | -4.13 Billion | 5.67 Billion | -2.9 Billion | 4.17 Billion |
| Free Cash Flow | 2.43 Billion | 17.35 Billion | 21.2 Billion | 16.28 Billion | 17.4 Billion | 14.08 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.88 Billion | 6.11 Billion | 23.21 Billion | 6 Billion | 4.93 Billion | 5.46 Billion |
| Depreciation & Amortization | 754.36 Million | 712.2 Million | 1.61 Billion | 417.28 Million | 399.08 Million | 402.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.98 Billion | -1.78 Billion | -2.57 Billion | -870.57 Million | 757.14 Million | -2.83 Billion |
| Other non-cash items | 7.06 Billion | 1.68 Billion | 5.45 Billion | 2.69 Billion | -211.42 Million | 4.13 Billion |
| Investing Cash Flow | 683.15 Million | 3.8 Billion | -16.35 Billion | -7.43 Billion | -10.17 Billion | 1.46 Billion |
| Investments in PPE | -290.65 Million | -1.21 Billion | -20.82 Billion | -19.94 Billion | -162.84 Million | -585.13 Million |
| Acquisitions | - | - | 910 Thousand | - | - | 810 Thousand |
| Investment purchases | -45.7 Billion | -10 Billion | -186.61 Billion | -26.59 Billion | -30.01 Billion | -105 Billion |
| Sales/Maturities of investments | 46.7 Billion | 15 Billion | 191.1 Billion | 39.1 Billion | 20 Billion | 107 Billion |
| Other Investing Activities | -26.18 Million | 21.54 Million | -12.59 Million | 3 Million | 2.83 Million | 47.46 Million |
| Financing Cash Flow | -6.09 Billion | -152.46 Million | -5.91 Billion | -73.16 Million | -122.47 Million | -5.49 Billion |
| Debt repayment | -146.83 Million | -143.04 Million | -534.02 Million | -140.18 Million | -134.42 Million | -129.83 Million |
| Dividends payments | -5.86 Billion | - | -5.47 Billion | - | - | -5.47 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -79.61 Million | -9.42 Million | 91.79 Million | 67.02 Million | 11.95 Million | 110.63 Million |
| Accounts receivables | -2.25 Billion | -1.7 Billion | -2.1 Billion | 133.63 Million | -748.24 Million | -728.78 Million |
| Accounts payables | -275.2 Million | 1.32 Billion | 2.73 Billion | 94 Million | 2.2 Billion | -662.15 Million |
| Inventory | -429.14 Million | -2.96 Billion | -1.83 Billion | 306.37 Million | -1.99 Billion | 700.51 Million |
| Other working capital | -3.03 Billion | 1.56 Billion | -1.36 Billion | -1.4 Billion | 1.3 Billion | -2.13 Billion |
| Cash at beginning of period | 17.48 Billion | 11.88 Billion | 10.88 Billion | 11.51 Billion | 17.28 Billion | 15.76 Billion |
| Cash at end of period | 15.33 Billion | 17.48 Billion | 11.88 Billion | 11.88 Billion | 11.51 Billion | 17.28 Billion |
| Capital Expenditure | -290.65 Million | -1.21 Billion | -20.82 Billion | -19.94 Billion | -162.84 Million | -585.13 Million |
| Effect of forex changes on cash | 10.14 Million | 889.86 Thousand | 4.78 Million | -65.47 Million | -7.03 Million | -128.64 Million |
| Net cash flow / Change in cash | -2.14 Billion | 5.6 Billion | 998.06 Million | 368.11 Million | -5.77 Billion | 1.51 Billion |
| Free Cash Flow | 2.95 Billion | 731.44 Million | 2.43 Billion | -12 Billion | 4.37 Billion | 5.09 Billion |
SAME
002664
ARPC
029530
BPCP
6099